Dallah Healthcare - Public Comps and Valuation Multiples

Dallah Healthcare Overview

About Dallah Healthcare

Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Services/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.

Founded

1994

HQ

Employees

n/a

Website

dallahhealth.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue $1.0B

LTM EBITDA $223M

EV

$5.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Dallah Healthcare Financials

As of September 2025, Dallah Healthcare reported last 12-month revenue of $1.0B and EBITDA of $223M.

In the same period, Dallah Healthcare achieved $138M in LTM net income.

See Dallah Healthcare valuation multiples based on analyst estimates

Dallah Healthcare P&L

In the most recent fiscal year, Dallah Healthcare reported revenue of $856M and EBITDA of $200M.

Dallah Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Dallah Healthcare valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.0B	XXX	$856M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$322M	XXX	XXX	XXX
Gross Margin	n/a	XXX	38%	XXX	XXX	XXX
EBITDA	$223M	XXX	$200M	XXX	XXX	XXX
EBITDA Margin	21%	XXX	23%	XXX	XXX	XXX
EBIT	$166M	XXX	$156M	XXX	XXX	XXX
EBIT Margin	16%	XXX	18%	XXX	XXX	XXX
Net Profit	$138M	XXX	$126M	XXX	XXX	XXX
Net Margin	13%	XXX	15%	XXX	XXX	XXX
Net Debt	XXX	XXX	$462M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Dallah Healthcare including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.0B. EBITDA for the last twelve months was $223M. In the most recent fiscal year, Dallah Healthcare achieved $856M in revenue and $200M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.0B	Analyst estimates available to subscribers	$856M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$322M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	37.6% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$223M	Analyst estimates available to subscribers	$200M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	21.3% EBITDA margin	Analyst estimates available to subscribers	23.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$166M	Analyst estimates available to subscribers	$156M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	15.9% EBIT margin	Analyst estimates available to subscribers	18.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$138M	Analyst estimates available to subscribers	$126M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	13.2% net profit margin	Analyst estimates available to subscribers	14.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$462M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Dallah Healthcare

This financial data table provides comprehensive performance metrics for Dallah Healthcare, a company based in Saudi Arabia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Dallah Healthcare generated $1.0B in revenue over the last twelve months.
The company achieved $223M in EBITDA over the last twelve months.
Net income over the last twelve months reached $138M.

Fiscal Year Performance

In the most recent fiscal year, Dallah Healthcare reported $856M in total revenue.
Fiscal year EBITDA was $200M.
The company maintained a gross profit margin of 37.6% in the most recent fiscal year.
EBITDA margin for the fiscal year was 23.4%.
Net profit margin reached 14.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Dallah Healthcare. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Dallah Healthcare Stock Performance

Dallah Healthcare has current market cap of SAR 15.6B (or $4.2B), and EV of SAR 18.8B (or $5.0B).

Market Cap Evolution

Dallah Healthcare Stock Data

As of October 17, 2025, Dallah Healthcare's stock price is SAR 154 (or $41).

See Dallah Healthcare trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$5.0B	$4.2B	XXX	XXX	XXX	XXX	$1.36

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Dallah Healthcare Valuation Multiples

Dallah Healthcare's trades at 5.9x EV/Revenue multiple, and 25.0x EV/EBITDA.

See valuation multiples for Dallah Healthcare and 15K+ public comps

Dallah Healthcare Financial Valuation Multiples

As of October 17, 2025, Dallah Healthcare has market cap of $4.2B and EV of $5.0B.

Equity research analysts estimate Dallah Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Dallah Healthcare has a P/E ratio of 30.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$4.2B	XXX	$4.2B	XXX	XXX	XXX
EV (current)	$5.0B	XXX	$5.0B	XXX	XXX	XXX
EV/Revenue	4.8x	XXX	5.9x	XXX	XXX	XXX
EV/EBITDA	22.5x	XXX	25.0x	XXX	XXX	XXX
EV/EBIT	30.2x	XXX	32.1x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	30.2x	XXX	33.2x	XXX	XXX	XXX
EV/FCF	-183.0x	XXX	60.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Dallah Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Dallah Healthcare Margins & Growth Rates

Dallah Healthcare's last 12 month revenue growth is 14%

Dallah Healthcare's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Dallah Healthcare's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dallah Healthcare's rule of X is 57% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Dallah Healthcare and other 15K+ public comps

Dallah Healthcare Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	14%	XXX	20%	XXX	XXX	XXX
EBITDA Margin	21%	XXX	23%	XXX	XXX	XXX
EBITDA Growth	12%	XXX	17%	XXX	XXX	XXX
Rule of 40	36%	XXX	38%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	57%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	19%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial